a(MESH:"Lupus Coagulation Inhibitor")
In addition, 8 of 30 patients (27%) with unspecified warm or cold AIHA experienced an episode of venous thromboembolism (Pullarkat et al, 2002); of these, the presence of a lupus anticoagulant identified AIHA patients at higher risk for venous thromboembolism. PubMed:25307023
In addition, 8 of 30 patients (27%) with unspecified warm or cold AIHA experienced an episode of venous thromboembolism (Pullarkat et al, 2002); of these, the presence of a lupus anticoagulant identified AIHA patients at higher risk for venous thromboembolism. PubMed:25307023
BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.
If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.